Medical Device Classification in Indonesia: Class A, B, C & D Explained

Correctly classifying your medical device is the single most critical step in the Indonesian registration process. In Indonesia, the Ministry of Health (Kementerian Kesehatan or Kemenkes) enforces a risk-based classification system that dictates your regulatory pathway, documentation requirements, and associated costs.

According to Permenkes No. 62 of 2017, all medical devices must be accurately classified into one of four categories (Class A, B, C, or D) before they can be registered and distributed. A mismatch between your product’s actual risk profile and its submitted classification can lead to application rejection, delays, or the need to restart the entire registration process.

1. What Is Medical Device Classification in Indonesia?

Medical device classification in Indonesia is a regulatory framework used to categorize devices based on the potential risk they pose to patients and users. This system is aligned with the ASEAN Medical Device Directive (AMDD) and ensures that higher-risk devices undergo more rigorous scrutiny than lower-risk items.

The classification determines the level of assessment required by the Directorate General of Pharmaceutical and Medical Devices (Ditjen Farmalkes). It acts as the foundation for your entire market entry strategy in Indonesia.

2. Why Medical Device Classification Is Important for Registration

Understanding your classification early in the product lifecycle is essential for four key reasons:

1. Regulatory Pathway: It determines whether your device requires a simple administrative review or a full technical evaluation including clinical data assessment.
2. Documentation Requirements: Higher classes (C and D) require significantly more robust technical files, including clinical evaluation reports and extensive risk management documentation.
3. Approval Timeline: Processing times vary significantly. Class A devices are processed much faster than Class D devices, which require in-depth expert review.
4. Cost Implications: Non-Tax State Revenue (PNBP) fees paid to the government are tiered based on classification.

3. Overview of Medical Device Classes in Indonesia

Indonesia divides medical devices into four classes based on risk, ranging from Low Risk (Class 1A) to High Risk (Class 3D).

Class 1A Medical Devices — Low Risk

Class 1A devices pose the lowest risk to patients and users. They typically do not come into contact with the body for extended periods or are non-invasive.

• Definition: Devices with low risk that are generally non-invasive.
• Examples: Elastic bandages, examination gloves, tongue depressors, walking aids, non-sterile surgical scissors.
• Evaluation Time: 15 working days (imported) — up to 45 working days.
• Registration Fee (PNBP): IDR 1,500,000 (approx. USD 115).

Class 2B Medical Devices — Low to Moderate Risk

Class 2B devices carry a low to moderate risk. They may be invasive but are usually for short-term use, or they are non-invasive devices that channel fluids or modify biological samples.

• Definition: Devices with low-to-moderate risk.
• Examples: Surgical masks, hypodermic needles, suction catheters, blood pressure monitors, infusion sets.
• Evaluation Time: 30 working days (imported) — up to 90 working days.
• Registration Fee (PNBP): IDR 3,000,000 (approx. USD 230).

Class 2C Medical Devices — Moderate to High Risk

Class 2C devices present a moderate to high risk. This category often includes active devices used for monitoring or therapy, as well as long-term invasive devices.

• Definition: Devices with moderate-to-high risk, often sustaining life or strictly monitoring vital parameters.
• Examples: Lung ventilators, bone fixation plates, orthopedic implants, infusion pumps, patient monitors, X-ray machines.
• Evaluation Time: 30 working days (imported) — up to 90 working days.
• Registration Fee (PNBP): IDR 3,000,000 (approx. USD 230).

Class 3D Medical Devices — High Risk

Class 3D represents the highest risk category. These devices are usually implantable, support life, or are critical for diagnosing life-threatening conditions.

• Definition: High-risk devices that are critical for life support, heart function, or direct contact with the central nervous/circulatory system.
• Examples: Cardiac pacemakers, prosthetic heart valves, coronary stents, absorbable sutures, implantable defibrillators.
• Evaluation Time: 45 working days (imported) — up to 120 working days.
• Registration Fee (PNBP): IDR 5,000,000 (approx. USD 340).

4. Examples of Medical Devices in Each Class

The following table provides a quick reference to help identify where your product might fall.

5. How Indonesia Determines Medical Device Classification

The Ministry of Health does not classify devices arbitrarily. The classification is based on specific scientific criteria outlined in the regulatory guidelines:

• Duration of Use: How long the device is intended to be in contact with the patient is one factor considered in the classification process. The specific thresholds are defined in the Directorate General’s classification guidelines and should be verified directly against the applicable Kemenkes guidance document for your specific product category.
• Invasiveness: Whether the device enters the body through a body orifice or surgically, and how deep it penetrates (e.g., central circulatory system vs. skin contact).
• Active vs. Passive: Whether the device depends on a source of energy (electricity, compressed gas) to function.
• Intended Use: Whether the device is intended for diagnosis, therapy, monitoring, or cleaning/disinfection of other devices.

6. Who Determines the Classification in Indonesia?

The responsibility for determining the classification involves three parties:

1. The Manufacturer: The manufacturer is responsible for initially determining the classification based on your product’s design and intended use. If you work with ICI, we can help you determine your medical device’s classification accurately.
2. The Indonesian Authorized Representative (PAK): Your local distributor or license holder in Indonesia must review and confirm that the classification aligns with Indonesian regulations. If you work with ICI, we can help you determine your medical device’s classification accurately.
3. The Ministry of Health (Kemenkes): The final authority. During the online submission process via the Kemenkes portal, the evaluators will verify your classification. If they disagree, they may reject the application or request a re-classification, which often requires re-starting the application and paying new fees.

7. Common Mistakes When Determining Medical Device Class

• Misclassifying Diagnostic Devices: Assuming all diagnostic devices are low risk. If a diagnostic device creates a biological effect or uses radiation (like X-ray), it is likely Class 2C or 3D.
• Copying EU/US Class Blindly: While Indonesia follows GHTF, local interpretations can differ. A Class I device in the USA (FDA) is not automatically Class 1A in Indonesia. Always cross-reference with Permenkes 62/2017.
• Ignoring ‘System’ Classification: If you sell a system with multiple components (e.g., a suction machine with tubing), the classification is usually determined by the highest-risk component.
• Underestimating Risk to Save Costs: Deliberately classifying a Class 2C device as Class 2B to save on fees and avoid clinical data requirements is strictly prohibited and will result in rejection.

8. Medical Device Classification and Registration Requirements

Your classification dictates the depth of your technical dossier:

• Certificate of Free Sale (CFS): Required for all classes (1A, 2B, 2C, 3D) for imported devices.
• ISO 13485: Mandatory for the manufacturer of all device classes.
• Clinical Evaluation Report (CER): A Clinical Evaluation Report is required for any medical device that comes into contact with skin or body tissue, regardless of class (1A, 2B, 2C, or 3D). The depth and rigor of the CER will vary — a basic literature summary may be acceptable for Class 1A, while Class 3D requires a comprehensive, strictly scrutinized clinical evaluation.
• Post-Market Surveillance: Class 3D devices often have stricter adverse event reporting timelines and post-market monitoring obligations.

9. Alignment with International Standards

Indonesia’s classification system does not exist in isolation. It is harmonized with:

• ASEAN Medical Device Directive (AMDD): Indonesia follows the standard ASEAN risk classification.
• Global Harmonization Task Force (GHTF): The principles of risk-based classification (Rule 1 to Rule 16) are derived from GHTF guidance.

This harmonization means that if your device is already registered in reference countries like the USA, EU, Canada, Japan, or Australia, the classification will likely be similar, though verification is still required.

10. Need Help Determining Your Medical Device Classification in Indonesia?

Determining the correct classification is not always straightforward, especially for borderline products or novel technologies. A misstep here costs time and money.

At ICI (INSIGHTOF Consulting Indonesia), we assist manufacturers and importers with:

• Product classification consultation
• Technical dossier preparation
• IDAK and CDAKB licensing support
• REGALKES submission and follow-up
• Post-registration compliance management

Conclusion

Successfully registering a medical device in Indonesia begins with accurate classification. By understanding the difference between Class 1A, 2B, 2C, and 3D, manufacturers and distributors can accurately predict their time-to-market, budget effectively for government fees, and prepare the correct technical documentation. Always rely on the intended use and risk profile of your device rather than simply copying classifications from other jurisdictions.